Mostrar el registro sencillo del ítem

dc.contributorUniversitat Ramon Llull. La Salle
dc.contributor.authorPeiro, Joan Carles
dc.date.accessioned2025-07-11T10:22:07Z
dc.date.available2025-07-11T10:22:07Z
dc.date.issued2021-05-31
dc.identifier.issn1557-8593ca
dc.identifier.urihttp://hdl.handle.net/20.500.14342/5407
dc.description.abstractBackground and Aims. This study will prove that diabetes T1 therapy by means of artificial pancreas consisting on insulin pump with CGM and hybrid close loop control algorithm trained with machine learning technology provides better glycemia control than multi daily injection, insulin pump without CGM and insulin pump with CGM in partially open loop therapiesca
dc.format.extent3 p.ca
dc.language.isoengca
dc.publisherMary Ann Liebert, Inc. Publishersca
dc.relation.ispartofThe Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference, 2-5 juny. Virtual Diabetes Technology & Therapeutics, Vol. 23, Suplement 2: Maig 31, 2021ca
dc.rights© 2025 Sage Publications. Tots els drets reservatsca
dc.subject.otherDiabetisca
dc.subject.otherDiabetis--Tractamentca
dc.subject.otherAprenentatge automàticca
dc.titleComparing “hybrid closed loop” artificial pancreas therapy to multi daily injection, insulin pump without CGM and insulin pump with CGM in partially open loop therapies for diabetes type-1 patientsca
dc.typeinfo:eu-repo/semantics/conferenceObjectca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc004ca
dc.subject.udc61ca
dc.subject.udc616.4ca
dc.subject.udc62ca
dc.identifier.doihttp://hdl.handle.net/20.500.14342/5406ca
dc.description.versioninfo:eu-repo/semantics/acceptedVersionca


Ficheros en el ítem

 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Compartir en TwitterCompartir en LinkedinCompartir en FacebookCompartir en TelegramCompartir en WhatsappImprimir